Brief: Guardant Health Shield Platform Selected For Inclusion In National Cancer Institute’S Vanguard Study To Evaluate Emerging Technologies For Multi-Cancer Detection
07/01/2025 13:18
Jan 7 (Reuters) - Guardant Health Inc GH.O :
* GUARDANT HEALTH SHIELD PLATFORM SELECTED FOR INCLUSION IN
NATIONAL CANCER INSTITUTE’S VANGUARD STUDY TO EVALUATE EMERGING
TECHNOLOGIES FOR MULTI-CANCER DETECTION
Source text: ID:nBw8GKk0Za
Further company coverage: GH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte